Biologics Market Demand, Drivers and Opportunities 2025-2030 |...

Biologics Market Demand, Drivers and Opportunities 2025-2030

Сообщение 2025-02-27 06:59:25

3Кб

Markntel Advisors’ report, Biologics Research Report: Trend, Business Growth, Size, Future Scope, Segmentation, Dynamics, and Forecast to 2030, offers a comprehensive guide for the growing industry. The expert team of analysts dedicated significant effort to gathering and evaluating the latest market data, resulting in a detailed and up-to-date report that offers valuable insights for individuals who rely on data-driven decisions, including business owners and analysts. The research report on the Biologics presents well-researched facts and figures pertinent to the industry, whether the goal is to explore new markets, launch a new product, or maintain a competitive advantage.

Biologics Market Research Report & Market Summary:

The Global Biologics Market size was valued at USD 412 Billion in 2024 and is projected to reach USD 612 Billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 8.25% during the forecast period, i.e., 2025-2030. The surging expenditures in healthcare, a hike in the sedentary lifestyles of individuals, and the rising number of chronic disease patients are some of the highlighting aspects promoting the industry growth. Other factors driving the demand for biologics across the global scale include enhanced usage of monoclonal antibodies for disease treatment, innovation & advancement in the healthcare & biotechnology sectors, and to cure diseases, including anemia, rheumatoid arthritis, osteoporosis, Alzheimer's, etc. Also, diseases like cancer and autoimmune disorders, which pose significant healthcare challenges, underscore the importance of targeted therapeutic interventions, and hence, have been driving the need for biologics over the historical years.

If you’re interested in the assumptions considered in this study, you can download the PDF brochure- https://www.marknteladvisors.com/query/request-sample/global-biologics-market.html

Biologics Market Dynamics:

Key Driver-

Increasing Inclination Towards Gene Therapy & Cellular Therapy to Boost the Market Growth – Due to their ability to repair or substitute damaged tissues, gene and cellular treatments have experienced considerable growth in adoption over the historical years. Moreover, the rising investments in research & development of cell and gene therapies have been further bolstering their adoption, owing to the improved efficacy of new drugs. Additionally, there has been increased funding and investments for R&D purposes of cell and gene therapies by companies like Ori Biotech, AstraZeneca Plc, GlaxoSmithKline Biologicals, etc., for the launch of innovative products.

Thus, with enhanced investment, the process of pre-commercialization and market launch has been accelerated, which has been contributing to the market growth. Also, over the historical years, the approvals of these medicines have been accelerated by government organizations like the United States Food and Drug Administration (FDA), the European Medicines Agency (EMA), etc. Consequently, as approvals for cell and gene therapies would accelerate in the coming years, it would create an opportunity for their enhanced adoption in the coming years as well.

Biologics Market Segmentation Analysis:

According to MarkNtel study the market is segmented into the following categories:

By Therapeutic Application

Oncology- Market Size & Forecast 2020-2030, (USD Million)
Infectious Disease- Market Size & Forecast 2020-2030, (USD Million)
Autoimmune Disease- Market Size & Forecast 2020-2030, (USD Million)
Diabetes- Market Size & Forecast 2020-2030, (USD Million)
Cardiovascular Diseases- Market Size & Forecast 2020-2030, (USD Million)
Others (Inflammatory Bowel Diseases, Respiratory Disorders, Ophthalmic Disorders, etc.)- Market Size & Forecast 2020-2030, (USD Million)

The Oncology segment witnessed substantial market growth during historical years. Oncology has been one of the largest markets for biologics due to the high unmet demand for effective cancer treatments. Biologics such as monoclonal antibodies and immune checkpoint inhibitors have revolutionized cancer treatment by targeting specific proteins or cells.

By Drug Class

Recombinant Proteins- Market Size & Forecast 2020-2030, (USD Million)
- Hormones- Market Size & Forecast 2020-2030, (USD Million)
- Cytokines- Market Size & Forecast 2020-2030, (USD Million)
Monoclonal Antibodies- Market Size & Forecast 2020-2030, (USD Million)
Blood & Blood Components- Market Size & Forecast 2020-2030, (USD Million)
Cellular & Gene Therapy- Market Size & Forecast 2020-2030, (USD Million)
Vaccines- Market Size & Forecast 2020-2030, (USD Million)
Others- Market Size & Forecast 2020-2030, (USD Million)

Monoclonal Antibodies (mAbs) have been gaining traction because of their capability to treat illnesses such as cancers, autoimmune issues, and infections. Advances in antibody engineering & hybridoma technologies have led to the creation of precise and powerful mAbs, therefore contributing to the growth of the Global Biologics Market.

By Source

Microbes- Market Size & Forecast 2020-2030, (USD Million)
Humans- Market Size & Forecast 2020-2030, (USD Million)
Others (Rodents, Plants, etc.)- Market Size & Forecast 2020-2030, (USD Million)

By Region

North America
South America
Europe
The Middle East & Africa
Asia-Pacific.

North America held the major share of the Global Biologics Market. The dominance of North America has been attributed to its sturdy healthcare infrastructure & great investments in biopharmaceutical studies. Also, as North America hosts a significant number of biopharmaceutical companies and research establishments that foster innovation, it has become a promising location for future market development.

As indicated in the latest market research report published by Markntel Advisors, “Biologics Research Report: Forecast (2025-2030)”, this report offers a detailed analysis of the industry, featuring insights into the Biologics industry. It encompasses competitor and geographical analyses, as well as recent advancements in the market.

Browse Full Report Along with TOC and Figures - https://www.marknteladvisors.com/research-library/global-biologics-market.html

Top Companies Operating in the Biologics Market:

Bristol-Myers Squibb
Pfizer
Sanofi
Janssen Biotech, Inc.
Bayer AG
Merck & Co.
Amgen Inc.
Abbott GmbH
Novartis
AstraZeneca Plc
GlaxoSmithKline Biologicals
Moderna, Inc.
Ferring Pharmaceuticals Inc.
Aimmune Therapeutics, Inc.
Hoffman La Roche

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel, and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address*

Other Report:

Key Report Highlights:

Market Dimensions & Projections
Pricing Evaluation,
Recent Strategic Moves by Companies,
Primary Stakeholders,
Analysis of Import and Export Trends,
Competitive Landscape Assessment,
Emerging Opportunities,
Market Trends and Indicators

Note - If there are any particular details you need that are not currently included in the report, we will be happy to provide them as part of our customization services.

Frequently Asked Questions (FAQs)-

What are the industry’s overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares)?
What are the trends influencing the current scenario of the market?
What leading factors would propel and impede the industry across the geography?
How has the industry been evolving in terms of geography & Biologics Market adoption?
How has the competition been shaping up across the geography?

Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?

About Us –

We are a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.